V, N., JS, B., IY, J., SF, L., AJ, R., MM, D., . . . NB, H. (2022). PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: A phase 1 trial. Nature medicine, 28(4), 724. https://doi.org/10.1038/s41591-022-01726-1
Chicago Style (17th ed.) CitationV, Narayan, et al. "PSMA-targeting TGFβ-insensitive Armored CAR T cells in Metastatic Castration-resistant Prostate Cancer: A Phase 1 Trial." Nature Medicine 28, no. 4 (2022): 724. https://doi.org/10.1038/s41591-022-01726-1.
MLA (9th ed.) CitationV, Narayan, et al. "PSMA-targeting TGFβ-insensitive Armored CAR T cells in Metastatic Castration-resistant Prostate Cancer: A Phase 1 Trial." Nature Medicine, vol. 28, no. 4, 2022, p. 724, https://doi.org/10.1038/s41591-022-01726-1.